Review



human umbilical vein ndothelial cells huvecs  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC human umbilical vein ndothelial cells huvecs
    Human Umbilical Vein Ndothelial Cells Huvecs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4893 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+vein+ndothelial+cells+huvecs/pm25442276-45-0-7?v=ATCC
    Average 99 stars, based on 4893 article reviews
    human umbilical vein ndothelial cells huvecs - by Bioz Stars, 2026-08
    99/100 stars

    Images



    Similar Products

    99
    ATCC human umbilical vein ndothelial cells huvecs
    Human Umbilical Vein Ndothelial Cells Huvecs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+vein+ndothelial+cells+huvecs/pm25442276-45-0-7?v=ATCC
    Average 99 stars, based on 1 article reviews
    human umbilical vein ndothelial cells huvecs - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    98
    PromoCell primary human umbilical vein ndothelial cells huvec
    Figure 1. SH2-domain containing tyrosine phosphatase-1 (SHP-1) is constitutively active in endothelial cells and degraded by antisense- magnetofection. Magnetofection of antisense oligodesoxynucleotide (AS- ODN) against SHP-1 into human umbilical vein endothelial cells <t>(HUVEC)</t> resulted in deprivation of its protein associated with a loss of SHP-1 activity. Note that there is remarkable activity of SHP-1 in HUVEC grown under control conditions (random ODN, similar activity observed in untransfected cells, see Fig. 4). **Significantly different vs. control at p 0.01.
    Primary Human Umbilical Vein Ndothelial Cells Huvec, supplied by PromoCell, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+vein+ndothelial+cells+huvecs/pm15893190-36-0-36?v=PromoCell
    Average 98 stars, based on 1 article reviews
    primary human umbilical vein ndothelial cells huvec - by Bioz Stars, 2026-08
    98/100 stars
      Buy from Supplier

    Image Search Results


    Figure 1. SH2-domain containing tyrosine phosphatase-1 (SHP-1) is constitutively active in endothelial cells and degraded by antisense- magnetofection. Magnetofection of antisense oligodesoxynucleotide (AS- ODN) against SHP-1 into human umbilical vein endothelial cells (HUVEC) resulted in deprivation of its protein associated with a loss of SHP-1 activity. Note that there is remarkable activity of SHP-1 in HUVEC grown under control conditions (random ODN, similar activity observed in untransfected cells, see Fig. 4). **Significantly different vs. control at p 0.01.

    Journal: Journal of the American College of Cardiology

    Article Title: The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation.

    doi: 10.1016/j.jacc.2005.02.039

    Figure Lengend Snippet: Figure 1. SH2-domain containing tyrosine phosphatase-1 (SHP-1) is constitutively active in endothelial cells and degraded by antisense- magnetofection. Magnetofection of antisense oligodesoxynucleotide (AS- ODN) against SHP-1 into human umbilical vein endothelial cells (HUVEC) resulted in deprivation of its protein associated with a loss of SHP-1 activity. Note that there is remarkable activity of SHP-1 in HUVEC grown under control conditions (random ODN, similar activity observed in untransfected cells, see Fig. 4). **Significantly different vs. control at p 0.01.

    Article Snippet: Primary human umbilical vein ndothelial cells (HUVEC) were harvested from umbilical ords by digestion with dispase (2.4 U/ml) and grown to onfluence in medium 199 supplemented with 20% neworn calf serum and 20% endothelial growth medium Promocell, Heidelberg, Germany) as previously described HUVEC medium) (21). agnetofection of oligonucleotides.

    Techniques: Magnetofection, Activity Assay, Control

    Figure 5. SH2-domain containing tyrosine phosphatase-1 (SHP-1) down- regulates reduced nicotinamide adenine dinucleotide (phosphate) (NAD[P]H)-oxidase activity. (A) Specific inhibitory peptides against NAD(P)H-oxidase (gp91ds-tat, 100 mol/l) abrogated the increase in O2 · release in human umbilical vein endothelial cell (HUVEC) mono- layers that was caused by sodium stibogluconate (SS). (B) NADH- dependent O2 · production in HUVEC protein lysates was increased 3.3-fold after treatment of cells with antisense oligodesoxynucleotide (AS-ODN) against SHP-1 but not with random ODN. *, **Significantly different vs. control at p 0.05 and p 0.01, respectively; ##significantly different vs. SS at p 0.01.

    Journal: Journal of the American College of Cardiology

    Article Title: The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation.

    doi: 10.1016/j.jacc.2005.02.039

    Figure Lengend Snippet: Figure 5. SH2-domain containing tyrosine phosphatase-1 (SHP-1) down- regulates reduced nicotinamide adenine dinucleotide (phosphate) (NAD[P]H)-oxidase activity. (A) Specific inhibitory peptides against NAD(P)H-oxidase (gp91ds-tat, 100 mol/l) abrogated the increase in O2 · release in human umbilical vein endothelial cell (HUVEC) mono- layers that was caused by sodium stibogluconate (SS). (B) NADH- dependent O2 · production in HUVEC protein lysates was increased 3.3-fold after treatment of cells with antisense oligodesoxynucleotide (AS-ODN) against SHP-1 but not with random ODN. *, **Significantly different vs. control at p 0.05 and p 0.01, respectively; ##significantly different vs. SS at p 0.01.

    Article Snippet: Primary human umbilical vein ndothelial cells (HUVEC) were harvested from umbilical ords by digestion with dispase (2.4 U/ml) and grown to onfluence in medium 199 supplemented with 20% neworn calf serum and 20% endothelial growth medium Promocell, Heidelberg, Germany) as previously described HUVEC medium) (21). agnetofection of oligonucleotides.

    Techniques: Activity Assay, Control

    Figure 4. Influence of vascular endothelial growth factor (VEGF) on SH2-domain containing tyrosine phosphatase-1 (SHP-1) activity and superoxide production. (A) Stimulation with VEGF (10 ng/ml) enhanced basal phosphatase activity of SHP-1 in human umbilical vein endothelial cells (HUVEC). (B) VEGF (10 ng/ml) also increased HUVEC O2 ·

    Journal: Journal of the American College of Cardiology

    Article Title: The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation.

    doi: 10.1016/j.jacc.2005.02.039

    Figure Lengend Snippet: Figure 4. Influence of vascular endothelial growth factor (VEGF) on SH2-domain containing tyrosine phosphatase-1 (SHP-1) activity and superoxide production. (A) Stimulation with VEGF (10 ng/ml) enhanced basal phosphatase activity of SHP-1 in human umbilical vein endothelial cells (HUVEC). (B) VEGF (10 ng/ml) also increased HUVEC O2 ·

    Article Snippet: Primary human umbilical vein ndothelial cells (HUVEC) were harvested from umbilical ords by digestion with dispase (2.4 U/ml) and grown to onfluence in medium 199 supplemented with 20% neworn calf serum and 20% endothelial growth medium Promocell, Heidelberg, Germany) as previously described HUVEC medium) (21). agnetofection of oligonucleotides.

    Techniques: Activity Assay